![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Teva, Lundbeck Announce European Approval for Azilect
Teva, Lundbeck Announce European Approval for Azilect
Teva Pharmaceutical Industries and H. Lundbeck A/S has announced that the European Commission issued a marketing authorization valid throughout the European Union for Azilect (rasagiline 1 mg, once daily), for the treatment of Parkinson's disease (PD) both as monotherapy in patients with early PD and as adjunct treatment in moderate-to-advanced disease.
The companies intend to market the product in various countries across Europe during the second quarter 2005.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
11Jul
-
18Jul
-
21Oct